Elocom
Elocom
- Available in community pharmacies and online; Elocom (mometasone furoate 0.1%) is prescription-only in most jurisdictions (including many parts of Canada and the EU), although in some local pharmacies or online vendors it may be sold or supplied without a prescription—always check local regulations and consult a pharmacist or prescriber.
- Elocom is a potent topical corticosteroid used to treat inflammatory skin conditions such as atopic dermatitis, eczema, psoriasis (not usually on face/groin/axillae), seborrheic dermatitis, lichen planus and similar dermatoses. Its mechanism is activation of glucocorticoid receptors in the skin, producing anti‑inflammatory, antipruritic and vasoconstrictive effects and reducing inflammatory mediator release.
- Usual adult dosage: apply a thin layer to the affected area once daily. For scalp conditions use the lotion/solution once daily. For children use sparingly and for the shortest effective duration; generally avoid in children under 2 years and limit courses in children to under about 3 weeks when possible.
- Topical administration: cream, ointment or lotion/solution applied directly to the skin (do not use ophthalmically, orally or intravaginally).
- Onset time: patients may notice symptomatic improvement (reduced itching and redness) within 24 hours, with clearer clinical improvement over several days; full response depends on condition severity.
- Duration of action: effects are sustained with once‑daily application (approximately 24 hours); recommended courses are typically short (1–2 weeks for acute flares) with periodic review for longer or chronic use.
- Alcohol warning: there is no specific systemic alcohol restriction for topical use, but avoid applying alcohol-containing products to treated skin and avoid excessive/prolonged use that could increase systemic absorption; discuss alcohol use and overall health with your prescriber if concerned.
- Most common side effec: local reactions such as burning, stinging, irritation, itching, dryness, folliculitis, acneiform eruptions, hypopigmentation and, with prolonged or excessive use, skin atrophy.
- Would you like to try elocom without a prescription?
Basic Elocom Information
- INN (International Nonproprietary Name): Mometasone furoate
- Brand Names Available In Canada (English): Elocon (Organon) and generics such as Mometasone Sandoz, Mometasone Teva, Glenmark/Momate where supplied
- ATC Code: D07AC13 (Corticosteroids, potent, group III, for topical use)
- Forms & Dosages: Cream 0.1% (15 g, 30 g tubes); Ointment 0.1% (15 g, 30 g tubes); Lotion 0.1% (30 mL bottle)
- Manufacturers In Canada (English): Organon (original supplier) and multiple generic manufacturers globally (Glenmark, Teva, Sandoz) — availability in Canada depends on distributor agreements
- Registration Status In Canada (English): Prescription-only topical corticosteroid products require Health Canada approval and carry a Drug Identification Number (DIN) to be marketed; specific DIN listings vary by product and distributor
- OTC / Rx Classification: Prescription Only (Rx)
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Canadians most often find Elocon or mometasone generics stocked at major chains and community pharmacies across provinces.
Availability can vary by store, with some outlets carrying branded Elocon and others dispensing generics such as Mometasone Teva or Mometasone Sandoz depending on distributor contracts.
Provincial drug programs reference DINs for coverage, so which exact brand a pharmacy dispenses can affect reimbursement for seniors or those on public plans.
Pharmacist counselling at these chains helps patients understand substitution, DIN checks, and safe use when dispensing a potent topical steroid.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Canadian online pharmacies increasingly offer home delivery and price-competitive options for prescription topical steroids.
Licensed online pharmacies require a valid prescription and should be registered with a provincial pharmacy regulatory authority.
Prices online are frequently comparable to or slightly lower than in-store, but provincial formularies and DIN matching still determine coverage and reimbursements.
Cross-border purchases from U.S. vendors remain common among Canadians seeking lower prices, but importation carries customs risk and non-Canadian products may lack a Canadian DIN.
Pricing Snapshot
| Store / Channel | Product / Size | Typical Price (CAD) | Notes |
|---|---|---|---|
| Shoppers Drug Mart (in-store) | Elocon Cream 0.1% 15 g | 12–40 | Brand or generic; price varies by location and formulary |
| Rexall (in-store) | Mometasone Generic 0.1% 30 g | 12–35 | Often dispenses generics depending on supplier contracts |
| London Drugs (Western Canada) | Elocon Ointment 0.1% 15 g | 15–40 | Stocking differs by province and store |
| Canadian Online Pharmacy | Generic Mometasone 0.1% 30 g | 12–30 | Requires prescription; discreet home delivery available |
| Cross-Border (US Vendors) | Elocon / Generic 15 g–30 g | Often lower, variable | Importation risks and may lack Canadian DIN; not eligible for provincial coverage |
Provincial differences matter: Ontario Drug Benefit (ODB), BC PharmaCare and Quebec’s RAMQ often list specific DINs for reimbursement and may require prior authorisation for selected products.
Online pharmacies in Canada usually match in-store pricing closely but can offer occasional discounts and free delivery thresholds.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
Many Canadians share lived experiences with Elocon on platforms like Reddit (r/SkincareAddiction, r/CanadaHealthcare), HealthBoards and clinic portals.
Discussion threads commonly focus on symptom relief, application technique, and worries about long-term steroid effects.
Patients report turning to pharmacists at major chains for clarification about substitution and provincial coverage.
Reported Benefits And Challenges From Canadian Patients
Common positive themes include rapid itch relief and convenient once-daily application.
Common concerns include skin thinning with prolonged use, confusion over brand versus generic substitution, and coverage issues tied to DIN listings.
Some Canadians share anecdotes about ordering U.S. or foreign generics to save money, often accompanied by warnings about counterfeit or mislabelled products.
- Pros: Fast symptom control, easy once-daily dosing, multiple formulations (cream/ointment/lotion) for different sites.
- Cons: Worries about long-term atrophy, variable provincial coverage, and paediatric dosing confusion.
Short anonymized quotes from forums:
"Started Elocon for a sudden eczema flare — itching stopped in two days, pharmacist helped with application tips."
"My plan wouldn't cover the branded DIN, so the pharmacy substituted a generic; still worked but paperwork was confusing."
These patient reports underline the need for pharmacist triage, clear counselling and assistance navigating provincial formularies.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
The International Nonproprietary Name (INN) is mometasone furoate.
Elocon is the original branded product from Organon and is available where supplied, while multiple generics (Mometasone Teva, Mometasone Sandoz, Glenmark/Momate) are distributed depending on contracts.
Formulations most commonly encountered are cream 0.1%, ointment 0.1% and lotion 0.1% for scalp use.
Legal Classification Under Health Canada
Topical mometasone products are prescription-only and subject to Health Canada oversight.
Products sold in Canada must carry a DIN that identifies formulation, strength and manufacturer for dispensing and coverage purposes.
Key Details
- ATC Code: D07AC13.
- Forms: Cream 0.1% (15 g/30 g), Ointment 0.1% (15 g/30 g), Lotion 0.1% (30 mL).
- Manufacturers: Organon (reference), generics by Glenmark, Teva, Sandoz and others.
| Brand | Common Package Sizes |
|---|---|
| Elocon (Organon) | Cream 15 g/30 g; Ointment 15 g/30 g; Lotion 30 mL |
| Mometasone Teva / Sandoz / Glenmark | Cream/Ointment 15 g/30 g (varies by supplier) |
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
Mometasone furoate 0.1% is used as a potent topical corticosteroid for inflammatory dermatoses.
Typical indications include atopic dermatitis, localized psoriasis (avoid face, groin and axillae unless prescribed), lichen planus, seborrheic dermatitis and other eczematous conditions.
Provincial formularies often reference DINs to determine which indications qualify for reimbursement or special-authority coverage.
Off-Label Patterns In Canadian Healthcare
Canadian physicians may use short courses of mometasone for localized lichen simplex chronicus or limited discoid lupus under specialist supervision.
Scalp disease often uses the lotion formulation for practicality and absorption on hairy sites.
Paediatric and pregnancy/lactation use is conservative, favouring short durations and physician monitoring.
| Indication | Typical Duration |
|---|---|
| Acute Atopic Dermatitis | 1–2 weeks, reassess |
| Localized Psoriasis | Short courses; avoid sensitive sites |
| Maintenance Strategy | Step-down to lower-potency steroid or non-steroidal topical for control |
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
Mometasone furoate is a topical steroid that calms inflamed skin and reduces redness, swelling and itch.
Applied as a thin layer once daily, it acts mainly where it is put and helps the skin regain normal appearance and comfort.
Topical use limits systemic exposure compared with oral steroids when used appropriately.
Clinical Detail From Health Canada Resources
Mometasone binds to glucocorticoid receptors in skin cells to lower cytokine production and reduce inflammatory cell infiltration.
Health Canada product monographs classify it as ATC D07AC13 and emphasise potency, application guidance, contraindications and the need to avoid prolonged or extensive use.
Systemic risks, such as HPA axis suppression, are possible with large-area application, occlusion or in young children, so monitoring is recommended in high-exposure scenarios.
Vehicle And Absorption Notes
- Creams absorb well and suit eczematous skin.
- Ointments are more occlusive and may increase absorption.
- Lotions/solutions are preferred for scalp application.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
Adults usually apply a thin layer once daily to affected areas; acute flares are commonly treated for 1–2 weeks.
Scalp formulations such as the 0.1% lotion are applied once daily to affected scalp areas.
For chronic conditions, prescribers aim for the lowest effective frequency and duration and schedule periodic reviews.
Adjustments By Patient Type (With Canadian Clinical Notes)
Children over 2 years may use mometasone sparingly, avoiding occlusion and large-area application; short courses (often under 3 weeks) are preferred.
Use in children under 2 years should only occur with specialist guidance because of systemic absorption risk.
Elderly patients require monitoring for skin thinning during prolonged treatment, but standard dosing is similar to adults.
| Patient Group | Dosing Notes |
|---|---|
| Adults | Thin layer once daily; 1–2 week course for flares |
| Children (>2 years) | Short courses, avoid occlusion, monitor closely |
| Infants (<2 years) | Not recommended without specialist input |
Pharmacists should counsel on fingertip unit dosing and when to seek medical review for prolonged or extensive use.
Contraindications & Side Effects
Common (Health Canada-Approved List)
Absolute contraindications include known hypersensitivity to mometasone or any excipients and untreated bacterial, viral, fungal or parasitic skin infections.
Conditions such as rosacea, acne vulgaris and perioral dermatitis are also contraindicated for topical corticosteroid use.
Common mild side effects include transient burning or stinging, itching, dryness, folliculitis and acneiform eruptions.
Rare But Serious (With Canadian Pharmacovigilance Data)
Prolonged or extensive use can cause skin atrophy, striae, telangiectasia and in rare cases systemic effects such as HPA axis suppression and Cushingoid features.
Canadian adverse reaction reports note rare systemic corticosteroid effects when topical products are misused, particularly in children or under occlusion.
Pregnancy and lactation are relative cautions; use only when necessary and under supervision.
| Contraindications | Monitoring Steps |
|---|---|
| Hypersensitivity; active skin infections | Stop product; refer to prescriber for alternative therapy |
| Use on face or large areas without supervision | Limit duration; consider lower potency alternatives |
| Children with extensive use | Monitor growth and consider HPA axis testing if prolonged |
Comparable Medicines In Canada
Alternatives Table (With DIN References)
Selection of an alternative depends on potency needs, site of application and patient factors.
| Comparator (INN / Brand) | Form | Potency Class | Pros / Cons |
|---|---|---|---|
| Betamethasone (Betnovate / Diprosone) | Cream / Ointment / Scalp | Potent (similar) | Widely stocked; comparable potency to mometasone |
| Fluticasone (Cutivate) | Cream / Ointment | Potent | Alternative potent steroid; stock varies by pharmacy |
| Triamcinolone (Kenalog) | Cream / Ointment | Variable potency | Useful in certain vehicles; potency depends on formulation |
| Clobetasol (Dermovate) | Cream / Ointment | Superpotent | Reserved for refractory disease; short-term use only |
Pros And Cons List
- Mometasone: Rapid control of inflammation; step-down strategy available.
- Betamethasone: Similar potency; often interchangeable clinically but check DINs for coverage.
- Clobetasol: Higher potency for short severe flares; increased risk of atrophy.
Pharmacists should verify therapeutic equivalence and DIN matching when substituting products for coverage or cost reasons.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent studies continue to evaluate potency, short-course effectiveness and steroid-sparing regimens for atopic flares.
Observational data from Canadian dermatology centres support once-daily mometasone for rapid control of acute flares with good short-term efficacy.
International randomized trials comparing mometasone to other potent steroids show similar efficacy when used appropriately but highlight the importance of safety monitoring.
Trends
There is growing emphasis on patient education to reduce topical steroid phobia and on pharmacist follow-up to prevent overuse.
Research into vehicle effects shows ointments increase occlusion and absorption, while lotions offer practical benefits for scalp disease.
Tele-pharmacy and virtual dermatologist follow-up are gaining traction in Canada to support safe monitoring and reduce unnecessary prolonged use.
| Study / Report | Design | Key Finding |
|---|---|---|
| Canadian Centre Observational Data (2023) | Observational | Once-daily mometasone effective for acute atopic flares |
| International RCTs (2022–2024) | Randomized Controlled Trials | Comparable efficacy among potent topical steroids when used correctly |
Common Patient Questions In Canada
Is Elocon covered by my provincial drug plan?
Coverage depends on the product DIN and provincial formulary; check ODB, PharmaCare or RAMQ and ask your pharmacist to verify specific DIN coverage.
Can I use Elocon on my face?
Generally avoid facial use except for short-term courses under physician guidance because facial skin is thinner and more prone to atrophy.
Is it safe for children?
Use sparingly in children older than 2 years for short courses and avoid occlusion; children under 2 years should only use it under specialist advice.
How quickly does it work?
Many patients notice improvement within a few days and more complete control within 1–2 weeks for acute flares.
What should I do if I run out?
Do not double up doses; contact your prescriber or pharmacist for a renewal or interim advice rather than increasing application frequency.
Always bring your prescription and ask the pharmacist about substitution, DIN-specific coverage and safe use.
Avoid buying topical steroids from unverified online sources without a prescription because of counterfeit or mislabelled risks.
Regulatory Status
Health Canada Approval Process
Products containing mometasone furoate must be approved by Health Canada and carry a Drug Identification Number to be marketed in Canada.
Approval evaluates quality, safety and efficacy and is supported by a Canadian product monograph from the manufacturer.
DIN Number Relevance
The DIN uniquely identifies the exact formulation, strength and manufacturer and is used by pharmacies and provincial drug plans for reimbursement and recalls.
Pharmacists and dispensing software routinely verify DINs before dispensing and counselling to ensure correct product substitution.
Imported products without a Canadian DIN may not qualify for provincial coverage and can be flagged at customs.
Visual Recommendations
Infographic Ideas For Canadian Context
Create a price-comparison table highlighting brand versus generic and in-store versus online channels with provincial callouts for ODB, PharmaCare and RAMQ.
Include a dosing quick-guide with a fingertip unit chart and sites requiring caution such as face and groin.
Add a safety decision tree showing when to stop treatment and when to see a pharmacist or physician.
Produce a micro-infographic comparing cream, ointment and lotion: usability, absorption and typical use cases.
Visual Block Specifications
Use bilingual labels where possible, a DIN callout box and icons for children, pregnancy and occlusion warnings.
Include clear CTA blocks such as "Ask Your Pharmacist" and "Check Provincial Coverage (link)".
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
Always obtain mometasone with a valid prescription from a Canadian prescriber or an authorised telemedicine consult.
Buying in-store at Shoppers Drug Mart, Rexall, London Drugs or a community pharmacy allows immediate pharmacist counselling and DIN verification.
Licensed Canadian online pharmacies can offer discreet home delivery and competitive pricing; verify provincial licensure and prescription requirements.
In our online pharmacy, elocom is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Cross-border purchases may be cheaper but risk lack of a Canadian DIN and possible customs holds or counterfeit products.
Proper Storage With Canadian Climate Considerations
Store at around 25°C with permitted excursions to 15–30°C and protect from freezing.
In Canadian winters avoid leaving tubes in a cold car where they could freeze; in summer avoid leaving them in hot vehicles where heat can degrade the product.
Keep the tube tightly closed, protect from light and discard after the expiry date.
| Storage Condition | Instruction |
|---|---|
| Room Temperature | Store at 25°C (77°F); acceptable 15–30°C |
| Winter Travel | Keep in insulated bag; avoid freezing |
| Summer Travel | Do not leave in hot car; keep out of direct sunlight |
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Confirm the indication, check for signs of infection and review age and pregnancy status before dispensing mometasone.
Explain the application: a thin layer applied once daily using fingertip unit guidance and avoiding occlusion unless directed.
Stress limiting duration—most acute flares respond within 1–2 weeks—and arrange follow-up for chronic or recurrent prescriptions.
Practical Monitoring And Follow-Up Steps
Document DIN, batch and expiry in the patient profile and schedule a review for repeat prescriptions.
For children or large-area use consider monitoring growth or HPA axis if prolonged high-exposure treatment is needed.
Advise the patient to stop therapy and seek review if the rash worsens, signs of infection appear or unexpected systemic symptoms occur.
- Counselling Checklist: Indication, dosing, duration, fingertip units, occlusion risks, signs to stop and follow-up plan.
- Monitoring Timeline: Review after 1–2 weeks for acute flares; earlier if side effects occur.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Quebec City | Quebec | 5-7 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
Quick Summary For Patients
Mometasone furoate (Elocon) 0.1% is a potent topical steroid available as cream, ointment and lotion for scalp disease.
It is prescription-only in Canada, and DINs determine which formula is covered by provincial plans.
Use a thin layer once daily for short courses (typically 1–2 weeks) and follow pharmacist or prescriber instructions for paediatric or sensitive-site use.
Store at controlled room temperature, buy from licensed Canadian pharmacies and consult your pharmacist about substitution or provincial coverage.